FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/08/2024
Back to search
Official data from USPTO
GLYCANOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GLYCANOSTICS
ST13
US500000079340032Class
5, 10, 35, 40, 41, 42, 44
Filing
79340032
Registration
7159631
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
01/08/2024
Trademark type
Word
Nice classes
5, 10, 35, 40, 41, 42, 44
Filing date
12/22/2021
Registration date
09/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2023
Last transaction
09/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SK
Examiner
BLAKESLEE, RICHARD A
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Glycanostics, s. r. o.
Representatives
Rhett V. Barney Lee & Hayes, PC
Technical classification
Nice Classes
Class 5Class 10Class 35Class 40Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
chemical preparations for pharmaceutical purposesfor calibration of diagnostics tests in a form of a glycoprotein standard; diagnostic preparations for medical purposes; chemical preparations for medical purposesfor diagnosis of oncological diseasesautoimmune diseases and neurological diseases; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic biomarker reagents for medical purposes; medical test sets comprised of enzymes for medical purposesantibodies for medical purposeslectins being glycan-recognising proteins for medical useglycoprotein standard for medical useenzymatic substrates for medical purposesblocking agents for medical useall for the diagnosis of diseases
Class 10
Blood testing apparatus; testing apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids; diagnostic apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids
Class 35
Retail store services for pharmaceutical preparationschemical preparations for pharmaceutical purposesdiagnostic preparations for medical purposeschemical preparations for medical purposesstem cells for medical purposesbiological tissue cultures for medical purposesdiagnostic biomarker reagents for medical purposesblood testing apparatustesting apparatus for medical purposesdiagnostic apparatus for medical purposesmedical test sets comprised of enzymes for medical purposesantibodies for medical purposeslectins being glycan-recognising proteins for medical useglycoprotein standard for medical useenzymatic substrates for medical purposesblocking agents for medical useall for the diagnosis of diseases; online retail store services for pharmaceutical preparationschemical preparations for pharmaceutical purposesdiagnostic preparations for medical purposeschemical preparations for medical purposesstem cells for medical purposesbiological tissue cultures for medical purposesdiagnostic biomarker reagents for medical purposesblood testing apparatustesting apparatus for medical purposesdiagnostic apparatus for medical purposesmedical test sets comprised of enzymes for medical purposesantibodies for medical purposeslectins being glycan-recognising proteins for medical useglycoprotein standard for medical useenzymatic substrates for medical purposesblocking agents for medical useall for the diagnosis of diseases
Class 40
Custom manufacture of medical test sets comprised of enzymes for medical purposesantibodies for medical purposeslectins being glycan-recognising proteins for medical useglycoprotein standard for medical useenzymatic substrates for medical purposesblocking agents for medical useall for the diagnosis of diseases
Class 41
Educational services in the nature of academiesconducting seminarsworkshopslecturespractical experimental demonstrations in the field of glycomicsbiomarker discoverydisease diagnosticsproteomicslife science company development; arranging and conducting of colloquiums in the field of glycomicsbiomarker discoverydisease diagnosticsproteomicslife science company development; arranging and conducting of conferences in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics; arranging and conducting of congresses in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics; arranging and conducting of seminars in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics; arranging and conducting of symposiums in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics; arranging and conducting of in-person educational forums in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics
Class 42
Chemical analysis; chemical research; biological research; scientific laboratory services; scientific research; medical and scientific researchconducting clinical validations trials for diagnostic and pharmaceutical companies; medical research
Class 44
Medical services; pharmacy advicepharmaceutical advice for diagnostic and pharmaceutical companies; health counselling; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Publications
History of USPTO decisions and trademark events.
37 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/14/2023
FIMP
FINAL DISPOSITION PROCESSED
12/14/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/26/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/24/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/24/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/12/2023
GNFR
FINAL REFUSAL E-MAILED
03/12/2023
CNFR
FINAL REFUSAL WRITTEN
03/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/26/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/13/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/13/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/13/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/13/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/13/2023
RFNP
REFUSAL PROCESSED BY IB
01/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/10/2022
RFRR
REFUSAL PROCESSED BY MPU
12/09/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/29/2022
CNRT
NON-FINAL ACTION WRITTEN
09/28/2022
DOCK
ASSIGNED TO EXAMINER
09/27/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/01/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/13/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/12/2022
Continuous trademark protection
Get notified about every new filing that threatens GLYCANOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.